Technology

AddToAny

Google+ Facebook Twitter Twitter

New breathalyser for disease

Owlstone Medical has announced the launch of its Breath Biopsy Kits.

New breathalyser for disease

 

The new product range allows academic, clinical and pharmaceutical researchers to quickly discover and validate breath-based biomarkers in early detection and precision medicine research activities.

Owlstone Medical’s Breath Biopsy platform is a new diagnostic modality capable of detecting biomarkers of disease, and also exogenous compounds, such as volatile drug metabolites, in breath.

The company’s ReCIVA Breath Sampler and new Breath Biopsy Kits ensure consistent and reliable collection of breath samples.

owlstonemedical.com

Related Articles

Creatine kinase molecule

Clinical chemistry classics pt 4b: cardiac markers

In the second instalment of his three-part look at cardiac markers, Stephen Clarke continues his historic analysis of landmark moments in clinical chemistry.

Nutrition and the elderly

Consultant Chemical Pathologist Ruth Ayling looks at the diets of those over 65 years old and examines why they have different nutritional needs from younger adults.

FIT for the future

Research and Development Scientist Carolyn Piggott looks at advances around faecal immunochemical tests for symptomatic groups. 

POCT blood tests for GPs

Blood tests to determine if patients need antibiotics are to be rolled out at doctors’ surgeries in Greater Manchester.

Top